Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer

Clinical trial NCT06711055 · RECRUITING

Trial details

NCT number: NCT06711055
Sponsor: Shu Wang
Status: RECRUITING
Study type: OBSERVATIONAL

HER2-positive Breast Cancer

Start date: 2015-01-01
Primary completion: 2031-12-31
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.